BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1227 related articles for article (PubMed ID: 31760627)

  • 1. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications.
    Liu G; David BT; Trawczynski M; Fessler RG
    Stem Cell Rev Rep; 2020 Feb; 16(1):3-32. PubMed ID: 31760627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming.
    Rony IK; Baten A; Bloomfield JA; Islam ME; Billah MM; Islam KD
    Cell Prolif; 2015 Apr; 48(2):140-56. PubMed ID: 25643745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Mesenchymal Stem Cells Through Stem Cell Reprogramming.
    Abdal Dayem A; Lee SB; Kim K; Lim KM; Jeon TI; Seok J; Cho AS
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
    Yoshihara M; Hayashizaki Y; Murakawa Y
    Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of human multipotent and pluripotent stem cells using surface nanotopographies and surface-immobilised bioactive signals: A review.
    Wang PY; Thissen H; Kingshott P
    Acta Biomater; 2016 Nov; 45():31-59. PubMed ID: 27596488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.
    Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M
    Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
    Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
    Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental approaches for the generation of induced pluripotent stem cells.
    Sommer CA; Mostoslavsky G
    Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming.
    Du Z; Jia L; Wang Y; Wang C; Wen X; Chen J; Zhu Y; Yu D; Zhou L; Chen N; Zhang S; Celik I; Ay F; Gao S; Zhang S; Li W; Hoffman AR; Cui J; Hu JF
    Sci Data; 2018 Nov; 5():180255. PubMed ID: 30457566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking Telomere Regulation to Stem Cell Pluripotency.
    Liu L
    Trends Genet; 2017 Jan; 33(1):16-33. PubMed ID: 27889084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of Human Induced Pluripotent Stem Cell (iPSC) Lines and Mechanism of Pluripotency: Historical Perspective and Recent Advances.
    Chhabra A
    Stem Cell Rev Rep; 2017 Dec; 13(6):757-773. PubMed ID: 28918520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis in Porcine Pluripotent Cells: From ICM to iPSCs.
    Kim E; Hyun SH
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27626414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs in the Regulation of Pluripotency and Reprogramming.
    Sherstyuk VV; Medvedev SP; Zakian SM
    Stem Cell Rev Rep; 2018 Feb; 14(1):58-70. PubMed ID: 29143182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upping the ante: recent advances in direct reprogramming.
    Müller LU; Daley GQ; Williams DA
    Mol Ther; 2009 Jun; 17(6):947-53. PubMed ID: 19337233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis.
    Lichner Z; Mac-Way F; Yousef GM
    Eur Urol Focus; 2019 Mar; 5(2):250-261. PubMed ID: 28847686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Methylation is Correlated with Pluripotency of Stem Cells.
    Wang R; Li T
    Curr Stem Cell Res Ther; 2017; 12(6):442-446. PubMed ID: 28025937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.